Logo do repositório
 
Publicação

Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis

dc.contributor.authorPerdigao, Joao
dc.contributor.authorMacedo, Rita
dc.contributor.authorRibeiro, Ana
dc.contributor.authorBrum, Laura
dc.contributor.authorPortugal, Isabel
dc.date.accessioned2015-12-30T10:18:21Z
dc.date.available2015-12-30T10:18:21Z
dc.date.issued2009
dc.description.abstractEthambutol (EMB) is a first-line antitubercular drug that inhibits arabinogalactan and lipoarabinomannan biosynthesis. Resistance to EMB has traditionally been associated with embB mutations, especially in the Met306 codon. In this study, the region encom. - Fundacao Calouste Gulbenkian, Lisbon, Portugal [FCG 001013]. - Funding: This work was supported by Fundacao Calouste Gulbenkian, Lisbon, Portugal (grant FCG 001013).
dc.formatapplication/pdf
dc.identifier.citationINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. - Vol. 33, n. 4 (APR 2009), p. 334-338
dc.identifier.doihttp://dx.doi.org/10.1016/j.ijantimicag.2008.09.021
dc.identifier.issn0924-8579
dc.identifier.urihttp://hdl.handle.net/10451/21542
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.subjectInfectious Diseases
dc.subjectMicrobiology
dc.subjectPharmacology & Pharmacy
dc.titleGenetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis
dc.titleprevalence and significance of embB306 mutations
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage338por
oaire.citation.startPage334por
oaire.citation.titleINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTSpor
oaire.citation.volumeVol. 33por
rcaap.rightsrestrictedAccess
rcaap.typearticle

Ficheiros